Home  >  Products  >  VAC14 (Vac14 homolog (S. cerevisiae) ) Blocking Peptide (the C terminal of VAC14)(100ug)
VAC14 (Vac14 homolog (S. cerevisiae) ) Blocking Peptide (the C terminal of VAC14)(100ug)

VAC14 (Vac14 homolog (S. cerevisiae) ) Blocking Peptide (the C terminal of VAC14)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-VAC14 Antibody (ARP61721_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61721
Size: 100ug
Weight: 86kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: The content of phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2) in endosomal membranes changes dynamically with fission and fusion events that generate or absorb intracellular transport vesicles. VAC14 is a component of a trimolecular complex that tightly regulates the level of PtdIns(3,5)P2. Other components of this complex are the PtdIns(3,5)P2-synthesizing enzyme PIKFYVE and the PtdIns(3,5)P2 phosphatase FIG4. VAC14 functions as an activator of PIKFYVE.
Alternative names: ArPIKfyve; FLJ10305; FLJ36622; FLJ46582; MGC149815; MGC149816; TAX1BP2; TRX
See Full Product Listings >